Mamaearth PPC & AI-Search Growth Opportunity Teardown

The thesis in one frame: shift the centre of gravity from buying attention to earning a place in the shortlist — across classic search and AI answers — while defending the brand-demand moat the company already paid to build.

Why we pulled this brand apart

Mamaearth is not a startup learning paid media. It is the flagship of India's largest digital-first beauty and personal care company by revenue, sitting inside a parent that deployed Rs 788 crore on advertising in FY26 alone. The interesting question is therefore not whether this brand can run ads, but whether a mature, ad-heavy machine is being pointed at the right surfaces as product discovery itself migrates away from the channels that built it.

This teardown maps that question end to end: the business model, the funnel, the Google and Meta engines, the keyword universe, the competitive set, the creative and CRO systems, a budget framework, and the discovery shift toward AI answer engines that will decide the next five years of beauty marketing in India. It is the same lens we bring to a paid-media engagement or an answer-engine-optimization programme for our own clients.

It is built entirely from public sources: company filings and earnings commentary, named industry and market data, observable advertising and landing-page behaviour, and structured strategic reasoning. Hard figures are cited where the company discloses them; where Mamaearth does not break out a number publicly, the analysis works with directional estimates and benchmark ranges and says so in plain language rather than presenting a guess as a fact. Nothing here relies on internal or proprietary data, and the full disclaimer at the end states this explicitly. The study is written so that any operator in this category, including a direct competitor, could read it and act on it.

One scope note before we begin. The Derma Co and Aqualogica are routinely grouped with Mamaearth's rivals. They are not competitors at all. Both are sister brands inside the same parent, Honasa Consumer, alongside BBlunt, Dr. Sheth's, Staze, Ayuga, the Nykaa-exclusive prestige line Lumineve, the acquired men's grooming brand Reginald, and the oral-care stake Fang Oral. This distinction reshapes the competitive and conquest sections below, so it is surfaced here at the top rather than buried.

Headline numbers at a glance

The position, read honestly

Before the plays, the snapshot. Where is this brand actually strong, and where is it exposed?

Five findings frame everything that follows.

First, Mamaearth is advertising-intensive, but less so than its peers. Honasa's FY26 ad spend of Rs 788 crore is roughly 33 percent of reported revenue (Rs 2,392 crore). That is a large number, but the wider D2C beauty norm runs 40 to 50 percent of revenue. The real story of FY25 into FY26 is a deliberate move away from raw performance spend toward brand-building and media-mix discipline.

Second, the growth deceleration of FY25 was a paid-acquisition warning shot. Revenue growth fell from roughly 28.6 percent in FY24 to about 8 percent in FY25 before recovering to roughly 20 percent in FY26. The recovery came from category focus, media-mix modelling, and awareness-led building, not from simply spending more. This is the clearest public signal that the cheap-paid-acquisition era has ended for the brand.

Third, the portfolio, not the single brand, is the real competitive unit. The Derma Co has crossed an annual revenue run rate above Rs 750 crore and is Euromonitor's number one sunscreen brand in India. Treating it as a conquest target would be self-cannibalisation.

Fourth, discovery is migrating to AI answer engines, and beauty is the front line. Roughly 37 percent of product-discovery queries now start in AI interfaces, and AI-referred shoppers convert at around 12.3 percent versus 3.1 percent for non-AI traffic. For an ingredient-led brand, this is both the largest risk and the largest unclaimed opportunity.

Fifth, the biggest opportunities and risks both cluster around the same shift. The opportunities: own the non-brand ingredient and concern universe before answer engines settle their citation patterns; convert review and editorial density into AI citations; tilt the paid mix toward retail media and quick commerce; and build retention and subscription economics. The risks: disintermediation by AI Overviews and chat assistants on exactly the queries Mamaearth's hero products are built to answer; well-capitalised strategic owners now controlling the fastest-growing rivals; and a tier mismatch, with the core sitting in the slower-growing mass-premium band while the 18 percent CAGR action is one tier up.

The strategic recommendation in one line: shift the marketing centre of gravity from buying attention on Meta and Google to earning inclusion in the shortlist, across both classic search results and AI answers, while protecting the brand-demand moat the company has already paid to build.

How the money actually works

Mamaearth sits inside a House of Brands, so the money has to be read at both the brand and the parent level.

The Mamaearth brand returned to double-digit growth in FY26 and re-took share in face cleansers, entering the top five in face wash. The parent does not break out brand-level revenue publicly, so this study works with the disclosed portfolio numbers and treats brand-level splits as directional.

The table below reads category-level value across the personal-care portfolio. Mamaearth does not disclose category splits, so the ranking is a directional read drawn from product salience, public commentary on hero SKUs, repeat-purchase logic, and category economics.

The most valuable categories combine high purchase frequency with defensible search intent: face wash and hair care. The highest-LTV category is arguably baby care, because it captures a household early and retains across a parenting lifecycle. The highest-margin categories are serums and sunscreen, which also happen to be where the premium tier and AI-driven ingredient discovery concentrate. The implication is that paid budget should over-index on hair care and face wash for efficient volume, while content and AI-visibility investment should over-index on serums, actives, and concern-led skincare to defend future margin. This is precisely the split a D2C growth programme has to get right.

The journey a buyer actually takes

The funnel below is built for an ingredient-led, mass-premium beauty brand selling across owned D2C, marketplaces, and quick commerce. The missed-opportunity column is where most of the upside lives.

The two cheapest sources of incremental revenue for a brand this mature are not at the top of the funnel — they are the consideration-to-evaluation band where AI answers now adjudicate, and the retention loop where owned channels can replace paid re-acquisition.

The structural insight is that for a brand of this maturity, the cheapest incremental revenue is no longer at the top of the funnel. It sits in two places this study keeps returning to: the consideration-to-evaluation band where AI answers now adjudicate, and the retention loop where owned channels can replace paid re-acquisition. A great deal of paid budget in mature D2C beauty is spent re-winning customers the brand already owns, which depresses blended return on ad spend without anyone in a single campaign seeing it.

The paid-search engine, reverse-engineered

This is a structural read of how a brand with Mamaearth's footprint runs search, reconstructed from observable ad behaviour, landing-page architecture, ad-copy patterns, the known hero SKUs, and category norms. The value is in the architecture and the gaps, both of which any operator can pressure-test against their own account.

What looks strong: brand-demand capture (years of brand investment mean enormous branded query volume to harvest cheaply), hero-SKU specificity (named products like Onion, Ubtan, Rice and Vitamin C give clean, high-intent keyword-to-landing-page matches), and offer cadence (frequent promotions suit Shopping and brand search).

What looks weak: non-brand category depth (if branded terms dominate the keyword profile, the brand is paying to capture demand it already created rather than expanding it) and concern-led intent (problem-aware queries like "hair fall treatment" and "acne face wash" are where new customers form preferences, and where AI answers are most active).

What looks missing: a deliberate answer-engine layer. Classic Google Ads does not address the share of "best X for Y" queries now resolved inside AI Overviews and chat, which sit above the paid auction entirely.

Four practical plays follow from that read. Lock brand impression share and run an ongoing reseller and sister-brand overlap check so the portfolio is not bidding against itself. Expand a non-brand category cell structured by ingredient plus concern plus form, mirrored exactly to PDP and content. Re-cut ad copy around proof, not adjectives — dermatologist-tested, clinically observed, specific concentrations — copy that doubles as AI-citation fodder. And use Performance Max as a feed-led engine, not a black box, with hero SKUs ring-fenced into their own asset groups — the discipline at the heart of any serious Google Ads programme.

The keyword universe. This is a keyword architecture rather than a volume dump. What drives allocation is not the raw number next to each term but its intent, funnel stage, commercial value, and priority. Volume bands are relative, not measured absolutes.

Paid efficiency is best protected on brand and product clusters — but future growth and the AI-search defence live in the solution-aware, ingredient-based and concern-based clusters, where the language of a paid query and the language of a ChatGPT prompt are now identical.

Brand cluster

Product cluster

Problem-aware cluster

Solution-aware cluster

Competitor cluster (external only)

Ingredient-based cluster

Concern-based cluster

Seasonal cluster

The one keyword principle that matters most: paid efficiency is best protected on brand and product clusters, but future growth and the AI-search defence live in the solution-aware, ingredient-based, and concern-based clusters. Those three are where the language of a paid query and the language of a ChatGPT prompt are now identical. Winning them in content and reviews is what gets a brand named when the auction disappears.

The competitor question everyone gets wrong

The Derma Co and Aqualogica are often listed as Mamaearth's rivals. They are sister brands inside Honasa Consumer, alongside BBlunt, Dr. Sheth's, Staze, Ayuga, the Nykaa-exclusive prestige line Lumineve, the acquired men's grooming brand Reginald, and the oral-care stake Fang Oral. Running competitor-conquest paid activity against any of these means paying to take clicks from the same parent. The portfolio is the moat, not the target. The genuine external set is narrower and, importantly, increasingly owned by strategic giants.

The fastest-growing rivals are being rolled up by HUL, Nykaa, KOSE and L'Oreal. Mamaearth and Honasa now sit among the few scaled independents left standing — a vulnerability and a positioning asset at once.

The pattern is unmistakable. The fastest-growing rivals are being rolled up by HUL, Nykaa, KOSE, L'Oreal, and others. Mamaearth and Honasa now sit among the few scaled independents left standing, which is simultaneously a vulnerability (deep-pocketed owners) and a positioning asset (the credible founder-led independent).

Opportunity score below weighs how winnable share is through paid conquest plus content. Difficulty weighs the rival's defensive strength. Scores run 1 to 10.

The conquest plays follow directly. Prioritise the weak and the overlapping (WOW, Biotique) for direct conquest search and comparison content. Flank, do not charge, the strong (Minimalist, CeraVe) — win "natural and clinically tested" rather than out-spending on "dermatologist". Treat comparison content as dual-purpose: a "Mamaearth vs X" page is both a conquest landing page and an AI-citation asset for "X alternative" prompts — exactly the kind of asset a content marketing programme is built to produce at scale. And never run conquest against the House of Brands — build a negative-keyword and exclusion governance layer across the portfolio's accounts.

The channel audits: Shopping, PMax, Meta and retention

Google Shopping and Performance Max. Shopping is where ingredient-and-concern intent converts, and where feed quality silently decides who wins.

The Shopping plays: re-title hero SKUs around the search query, not the shelf ("Mamaearth Vitamin C Face Wash for Oily Skin, with Vitamin C and Turmeric, 100ml" beats "Mamaearth Vitamin C Face Wash"); add concern-level product types (anti-hair-fall, oily-skin, dark-spots) so the feed can map to concern queries; fill every optional attribute, especially skin type and product highlights, because these increasingly feed both Shopping and AI shopping surfaces; and use Merchant Center promotions and ratings aggressively, since star ratings carry into how products are perceived and cited.

For a mature ecommerce advertiser, Performance Max is almost certainly running. The risk at this scale is that PMax becomes an unaccountable spend sink that quietly harvests brand demand and reports it as prospecting.

The recommended PMax architecture: separate brand from non-brand (use brand exclusions so PMax is measured on incremental, not harvested, demand); build concern-themed asset groups (hair fall, oily skin, sun protection, baby care), each pointed at a matching PDP or collection; feed every asset group proof-led creative (before-and-after where compliant, ingredient call-outs, dermatologist framing, review quotes); ring-fence hero SKUs into dedicated asset groups so winners are not diluted by the long tail; and instrument a clean conversion-value model so true incremental ROAS is visible to both marketing and finance.

Meta, creative and CRO. Meta remains the demand-generation engine for D2C beauty, but the economics have shifted: CPMs have risen, signal loss from privacy changes has degraded targeting, and the same audiences are contested by hundreds of brands. The category runs a recognisable repertoire of creative and offer patterns — founder and purpose storytelling, ingredient-led hooks (onion, ubtan, vitamin C, rice), before-and-after result framing, dermatologist endorsement, UGC-style testimonial video, problem-agitate-solve hooks, bundle and combo offers, festive promotions, free-gift mechanics, social-proof statics, "Made Safe" trust badges, creator collaborations, concern-specific carousels, routine education, myth-busting, seasonal angles, price-anchored value, app and subscription nudges, marketplace-availability cues, and quick-commerce immediacy.

Where do competitors do it better? Minimalist leans into restraint and clinical credibility, which reads as trust rather than noise — and in an AI-citation world, that clinical content compounds. Dot and Key runs vibrant, routine-led creative that bundles multiple SKUs into a single basket, lifting units per order. Foxtale and Pilgrim push high creative velocity, testing more hooks per week.

The plays here are about leverage, not budget. Increase creative velocity and proof density, not spend — at this maturity the constraint is winning creative, not reach. Build a UGC and creator engine whose outputs double as review and AI-citation material. And shift a measured share of Meta budget toward retail media and quick commerce, where purchase intent now concentrates — the same migration we map for ecommerce brands as the transaction moves off owned D2C.

The landing-page picture, scored 1 to 10 where 10 is best in class, reflects category norms and the brand's known assets:

The CRO finding that matters most: for a brand this far along, the highest-return work is not another hero-banner test. It is two things. First, structured proof on PDPs (reviews, clinical or dermatologist framing, FAQ schema, ingredient detail) that lifts human conversion and makes pages retrievable by answer engines — the machine-readability layer a technical SEO programme owns. Second, routine and bundle architecture that raises units per order, because in a rising-CPM world the cheapest way to improve blended economics is to sell more per checkout rather than win more checkouts.

The retention loop most brands underbuild. A mature advertiser's remarketing should be a layered audience architecture, not a single "all visitors" pool.

The remarketing thesis: the biggest unglamorous win for a brand spending at this level is to move replenishment and routine-completion off cold paid and onto owned channels (email, WhatsApp, app, subscription). Every customer retained through owned media is a customer who does not need to be re-bought at a rising CPM. This is the clearest path to lifting blended return on ad spend without cutting growth.

YouTube, which now pays twice. YouTube matters twice over. It is a major awareness and consideration surface in India, and it is the single largest citation source inside Google AI Overviews. Winning YouTube now pays a discovery dividend and an AI-visibility dividend at the same time.

The scripts should be written so the transcript itself becomes AI-citation material, since answer engines read YouTube transcripts heavily. A concern-led hook ("If your hair is falling more than usual, it is probably one of these three things") names the causes, positions the onion or rosemary range as the fix, and closes with proof and offer. An ingredient hook ("Dermatologists keep saying this about vitamin C, and most face washes get it wrong") explains the ingredient, shows the formulation, and closes with the hero SKU. A Shorts hook is a five-second visible result moment, then the product, then where to buy, including quick commerce.

On creative more broadly, fifty angles ranked by a blend of likely performance and AI-citation value cluster into three bands. The deploy-now (A) band is built around ingredient proof, before-and-after results, dermatologist explainers, concern solves (hair fall, oily skin), routine completion, "toxin-free / Made Safe" trust, real customer UGC, myth-busting, "best for [concern]" comparison, subscription value, bundles, sensitive-skin reassurance, sun-protection education, and baby-care lifecycle trust. The test (B) band covers ingredient origin, clinical framing, creator co-signs, seasonal angles, quick-commerce immediacy, price-value anchors, founder-led purpose, switch messaging, ingredient-vs-ingredient education, skin-type quizzes, awards, sustainability, festive gifting, men's crossover, concern bundles, sensory demos, regional-language creative, and first-purchase incentives. The situational (C) band holds loyalty, behind-the-formulation, community, cause tie-ins, limited drops, collaborations, trend-jacking, humour, day-in-the-life, unboxing, dupe framing, nostalgia, long-form expert interviews, data reveals, and shoppable streams. The principle: over-index the A band, which clusters around ingredient proof, concern-solving, and structured credibility — the angles that perform in paid and get cited in AI answers. Adjective-led brand fluff does neither.

The budget question

The one verified channel-level figure is the parent's total of Rs 788 crore in FY26 across the whole portfolio, roughly Rs 65 crore per month for all brands combined. The models below are recommended allocation frameworks for a single Mamaearth-scale brand programme, built on the 2026 D2C benchmark mix (Meta 40 to 50 percent, Google 25 to 30 percent split across Shopping, brand search, and Performance Max, 15 to 25 percent emerging channels, 5 to 10 percent testing), then adapted for a mature brand with heavy existing brand equity. The adaptation pulls budget toward Shopping, retail media, retention, and AI-search readiness, and away from raw top-funnel Meta.

As budget scales, the mature-brand version tilts steadily toward Shopping and PMax, retail media, retention and AI-search, and away from pure top-funnel Meta. A brand that already paid to create demand should spend proportionally more on capturing and retaining it.

Model A — Rs 10 lakh per month (focused single-category or pilot)

Model B — Rs 50 lakh per month (scaled single-brand)

Model C — Rs 1 crore per month (mature, full-funnel)

The allocation philosophy: as budget scales, the mature-brand version tilts steadily toward Shopping and PMax, retail media, retention, and AI-search, and away from pure top-funnel Meta. The logic is simple. A brand that has already paid to create demand should spend proportionally more on capturing and retaining it, and proportionally less on re-announcing itself to cold audiences at rising CPMs.

The shift that decides the next five years

This is the most consequential part of the teardown, and the one most likely to separate the brands that compound from the brands that quietly fade. Beauty and skincare are the front line of the discovery shift, because the questions buyers ask ("best vitamin C face wash for oily skin under 400") are exactly the questions answer engines are built to resolve. (If the terminology here is unfamiliar, our primer on SEO vs AEO vs GEO lays out the three layers.)

Old world: a sprawling feed and a list of ten links. New world: a single AI answer that compresses the choice set to roughly five products. Brands now compete for inclusion in a shortlist, not for attention in a feed.

The shift, in numbers: roughly 37 percent of product-discovery queries now begin in AI interfaces like ChatGPT and Perplexity. AI-referred shoppers convert at about 12.3 percent versus 3.1 percent for non-AI traffic, and spend meaningfully longer on site, because the AI has already done the comparison work. ChatGPT operates at very large scale, on the order of 900 million weekly users and roughly 2 billion queries a day, making it a discovery surface in its own right. When a shopper asks an AI for a skincare pick by sensation, concern, and price, the selection set compresses to roughly five products. And the most-cited sources inside Google AI Overviews are YouTube (about 23 percent), Wikipedia (about 18 percent), and Google.com (about 16 percent), while ChatGPT leans heavily on Reddit, major publications, and review platforms.

Each engine shapes beauty discovery a little differently.

The tactical playbooks differ by engine — we break them down in how to rank on ChatGPT and how to rank on Perplexity. | Copilot | Shopping-leaning, commerce-data-aware | Structured product data, ratings, retailer presence | | Claude | Reasoned, safety-aware recommendations | Clear evidence, credible authorship, consistent brand facts |

Where Mamaearth risks losing visibility: on solution-aware and ingredient queries ("best onion shampoo for hair fall", "vitamin C vs niacinamide", "best face wash for oily skin") that are AI-native, where thin review or editorial density hands the citation to a rival; on "dermatologist-recommended" framings, where CeraVe and Cetaphil hold a structural head start; and on comparison and "alternative" prompts, where whoever owns the comparison content owns the answer.

Where it can gain visibility: on natural-plus-clinically-tested positioning, a space neither the pure-clinical brands nor the pure-natural brands fully own; on hero-ingredient authority (onion, ubtan, rice, vitamin C), where the brand already has product-market fit and search demand to convert into citation authority; and on lifecycle and baby-care trust, a durable, emotionally weighted entity that AI engines can attach to the brand.

The AEO and GEO action plan has seven moves. Entity SEO and knowledge-graph development — make the brand and its hero products unambiguous machine-readable entities, because AI engines recommend what they can confidently identify. Ingredient content hubs — deep, evidence-led pages on each hero ingredient and concern, written to answer the exact prompts buyers type into AI; these are the highest-leverage assets in the entire plan. Comparison and experience content — honest "X vs Y" and "best for [concern]" pages that earn the comparison-prompt citations. Review acquisition at scale, concentrated on the surfaces AI cites most: marketplace reviews, YouTube, and credible Reddit presence. Expert citations and digital PR — editorial coverage and expert authorship that move a brand from "advertised a lot" to "trusted by experts" inside an AI's consensus layer; this is earned, not bought. Structured data everywhere — FAQ, product, review, and how-to schema on every hero page. And prompt-tracking as a KPI — measure how often, and how favourably, the brand appears across ChatGPT, Perplexity, Gemini, Claude, and AI Overviews for a defined prompt set, the AI-era analogue of rank tracking.

The urgency is real and time-boxed. The brands an AI names in 2026 will be hard to dislodge in 2027, because citation patterns compound. The window to claim ingredient and concern authority is open now and narrows as competitors wake up to it.

The roadmap and the verdict

A 12-month sequence.

The sequencing logic: fix the leaks and build the machine-readable foundation first, then expand acquisition and start the citation flywheel, then shift growth onto cheaper owned and earned channels, then consolidate the moat.

The verdict.

Strong raw ingredients — brand, hero SKUs, demand — but no visible deliberate AEO or GEO programme. AI-search readiness is the single biggest unguarded flank.

What Mamaearth is likely doing well: brand-demand creation at a scale almost no Indian D2C peer can match; hero-product discipline, with a small number of named, ingredient-led SKUs doing the heavy lifting; a genuine strategic pivot away from raw performance spend toward brand-building and media-mix discipline, visible in the FY26 recovery and margin expansion; and a House of Brands that functions as a compounding launch platform, not a single product line.

What Mamaearth is likely missing: a deliberate answer-engine strategy on exactly the ingredient and concern queries its products are built for; sufficient non-brand and concern-led search and content depth, leaving it paying to harvest demand it already created; retention and subscription economics strong enough to take replenishment off cold paid; and full weight behind retail media and quick commerce, where the purchase increasingly happens.

The biggest growth opportunities: own the ingredient and concern answer layer before competitors and before AI citation patterns harden; migrate replenishment to owned channels to structurally lift blended return on ad spend; and premiumise selectively (the Lumineve and serum direction) to enter the faster-growing tier without abandoning the mass-premium base. The most dangerous threats: AI disintermediation of branded and ingredient discovery; strategically owned rivals with deep pockets; and the tier-growth mismatch.

Mamaearth has already won the expensive battle: it built durable brand demand in a crowded category. The next battle is cheaper to fight but easier to lose by ignoring it. As discovery migrates from feeds and links to AI answers, the brands that win will be the ones an engine can identify, trust, and name inside a five-item shortlist. Mamaearth has the raw materials to be that brand for onion, ubtan, vitamin C, rice, and the concerns they solve. The single highest-return move is to convert its existing advertising-built equity into machine-readable, review-dense, expert-cited authority on its hero ingredients and concerns, while shifting paid budget steadily toward capture (Shopping, retail media), retention, and AI-search readiness, and away from re-announcing itself to cold audiences at rising CPMs. Defend the demand you paid to build. Then go and own the answer.

If you want this lens turned on your own brand, that is the work we do: a forensic SEO and AI-search audit, an AI SEO programme to build answer-engine authority, and the paid-media discipline to capture and retain the demand. Talk to us about a teardown of your own funnel →

Appendices: the supporting analysis

Appendix A — SWOT. Strengths and weaknesses are internal to the brand, opportunities and threats are external.

Strengths. Category-defining brand equity, top-of-mind in toxin-free, ingredient-led personal care with founder-led trust competitors cannot easily replicate. Hero-SKU economics, with a focused set of named products (Onion Shampoo, Ubtan and Rice face wash, Vitamin C range, Rosemary anti-hair-fall) doing the heavy lifting, Rice Face Wash reportedly reaching a Rs 100 crore ARR run rate. Scale and capital, the parent deploying Rs 788 crore on advertising in FY26 and turning a Rs 200 crore profit with its first-ever dividend declared. A House of Brands flywheel, with The Derma Co (above Rs 750 crore ARR, India's number one sunscreen by Euromonitor) proving the parent can incubate new winners faster each cycle. And omnichannel reach across own D2C, Amazon, Flipkart, Nykaa, and an offline footprint of 2.5 lakh-plus outlets and rising.

Weaknesses. Brand-search dependency, with the keyword profile skewing heavily branded, implying under-developed non-brand category capture. Thin structured proof for the AI era, with limited visible schema, clinical framing, and machine-readable evidence on hero pages. Retention under-leverage, with replenishment appearing to lean on paid re-acquisition rather than owned-channel and subscription loops. A tier ceiling, with the core sitting in the mass-premium (Rs 200 to 500) band, the slower-growing tier. And leadership churn, with a recent CMO transition introducing strategic-continuity risk.

Opportunities. Answer-engine authority on ingredient and concern queries, an open and time-boxed window. Retail media and quick commerce growth, capturing purchase intent where it now concentrates. Selective premiumisation into the faster-growing mid-premium tier via serums, actives, and the Lumineve direction. And conquest of weakening rivals such as WOW Skin Science and overlapping naturals like Biotique.

Threats. AI disintermediation of branded and ingredient discovery. Strategically owned competitors with deep capital: HUL behind Minimalist, Nykaa behind Dot and Key, KOSE behind Foxtale, L'Oreal and Galderma fielding CeraVe and Cetaphil. Rising CPMs and signal loss degrading paid efficiency across the category. And margin pressure if growth continues to require high advertising intensity.

Appendix B — Market structure and positioning. The Indian skincare and BPC market is best understood as a set of price tiers with very different growth rates. This is the structural backdrop to every recommendation here.

The positioning thesis: Mamaearth's centre of gravity sits in the tier with the slowest growth. That is not a crisis, because mass-premium is also the largest D2C-addressable tier and Mamaearth leads parts of it. But it does mean the brand's future growth ceiling depends on two moves: defending and consolidating mass-premium leadership through superior discovery, including AI search, and laddering selected buyers up into the mid-premium and prestige tiers through actives, serums, and the parent's premium launches. The content and AI-visibility recommendations serve both moves at once, because ingredient-led authority is exactly what pulls a mass-premium buyer toward a higher-consideration purchase.

Appendix C — Advertising-intensity benchmark. Because the only hard channel figure available is total ad spend, it is worth framing what that number means relative to peers.

The popular narrative that Mamaearth simply out-spends everyone is only half right. It spends a great deal in absolute terms, but proportionally less than the typical D2C beauty challenger, and it is actively reducing that proportion while still growing. The strategic risk is not that the brand spends too much. It is that a meaningful share of that spend may be pointed at channels and surfaces the discovery shift is eroding. Re-pointing spend, not cutting it, is the thesis.

Appendix D — AI-search risk and opportunity register. A concrete, prompt-level register of where the brand is most exposed and most able to win in answer engines. These are example buyer prompts any operator can run today to test their own visibility.

The highest-priority rows are where buyer language overlaps perfectly with a Mamaearth hero ingredient and a winnable price point. Those are the prompts to instrument in prompt-tracking first, to build ingredient-hub and review density around first, and to measure relentlessly. The "dermatologist recommended" rows are where the brand should flank rather than fight, leaning on natural-plus-tested rather than contesting pure clinical authority head-on.

Appendix E — KPI and measurement framework. A mature programme needs metrics for both the classic auction world and the emerging answer-engine world. The second column is the part most brands have not yet built.

What gets measured gets defended. Today almost every D2C dashboard measures the auction and ignores the answer. Standing up prompt-tracking and an owned-channel-share metric is, by itself, a competitive advantage, because it lets a brand see the discovery shift happening in time to act on it rather than after a quarter of unexplained ROAS decline.

Appendix F — Prioritisation model (impact vs effort). A consolidated ICE-style ranking of the recommendations, so the programme can be sequenced by return rather than by enthusiasm. Each initiative is scored 1 to 10 on Impact (revenue or efficiency upside), Confidence (how sure the play is to work), and Ease (inverse of effort and cost). The ICE score is the average, meant for relative sequencing rather than forecasting.

The "do first" tier is almost entirely cheap, fast, and high-confidence. It stops the leaks (self-cannibalisation, brand-demand harvesting misreported as prospecting) and lays the machine-readable foundation everything else builds on. The "build next" tier is where the durable advantage is created, and it is deliberately harder, because content depth, review density, and retention loops take time and cannot be bought overnight. The "scale later" tier compounds the moat once the foundation and the flywheel exist. A common and expensive mistake is to start with the glamorous "scale later" work before the foundation is in place, which wastes spend on surfaces a brand is not yet equipped to convert or measure.

---

Disclaimer: This study is based on publicly available information, observable advertising activity, third-party intelligence tools, and strategic inference. Hard figures are drawn from company filings, earnings commentary, and named industry sources. Where the company does not disclose a number, the analysis uses directional estimates and benchmark ranges, which are identified as such in the text. No claim is made that the authors have worked with, or had access to internal data from, Mamaearth or Honasa Consumer Limited.